Catalog |
name |
Description |
price |
R-Mcs-403 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Biotin Fluorescent Lipid Rhodamine lipid (headgroup) |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Biotin(57:38:4:1molar ratio) Fluorescent Lipid Rhodamine lipid (headgroup) is designed as a long-circulating, biotin-functionalized nanocarrier labeled with NBD lipid (headgroup), a fluorescent dye.
Ideal for:Deep-tissue tracking of drug carriers;Streptavidin-mediated targeting in animal models;Multimodal theranostic nanomedicine. |
price> |
R-Mcs-404 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiA |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiA is a PEGylated fluorescent liposome nanomaterials.
Incorporating DiA, a lipophilic carbocyanine dye (Ex/Em ≈ 450/590 nm), into the lipid bilayer for membrane fluorescence labeling and tracking. The amine-functionalized PEG allows further conjugation or surface modification. |
price> |
R-Mcs-405 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiD |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiD
is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em ≈ 644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-406 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiI |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiI is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-407 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiO |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiO is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-408 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiR |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid DiR is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-409 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine Fluorescent Lipid Dansyl lipid (headgroup) |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid Dansyl lipid (headgroup) is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-410 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine Fluorescent Lipid NBD lipid (fatty acid tail) |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine(57:38:4:1molar ratio)Fluorescent Lipid NBD lipid (fatty acid tail) is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-411 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine Fluorescent Lipid NBD lipid (headgroup) |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid NBD lipid (headgroup) is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |
R-Mcs-412 |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine Fluorescent Lipid Pyrene lipid (headgroup) |
HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Amine (57:38:4:1molar ratio)Fluorescent Lipid Pyrene lipid (headgroup) is a PEGylated fluorescent liposome nanomaterials.
End Uses:
In vivo and in vitro imaging:Near-infrared fluorescence (Ex/Em≈644/665 nm) allows deep-tissue imaging with low background autofluorescence.
Biodistribution and pharmacokinetic studies:Tracks liposome circulation, accumulation, and clearance in real time.
Cellular uptake and trafficking analysis:Visualizes liposome-cell interactions and intracellular fate.
Targeted delivery research:The amine-functionalized PEG enables ligand or antibody conjugation for targeted drug delivery systems.
Theranostic platform development:Can be combined with therapeutic agents to create image-guided drug delivery systems. |
price> |